KEYTRUDA

KEYTRUDA

Displaying 10 out of 7 results

  1. Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headquarters in Le

    Bristol-Myers posts better-than-expected results, Opdivo growth slows

    U.S. drugmaker Bristol-Myers Squibb Co reported higher-than-expected third-quarter profit on Thursday, helped by strong sales of blood thinner ...
  2. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat

    U.S. drugmaker Merck & Co Inc reported a 56.4per cent rise in second-quarter profit on Tuesday, boosted by strong demand for its Keytruda ...
  3. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda sets new five-year survival standard for advanced lung cancer

    Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive ...
  4. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's Keytruda fails as monotherapy in breast cancer study

    Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the treatment as a ...
  5. The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey

    Merck's first-quarter profit beats on Keytruda boost

    Merck & Co Inc reported a higher-than-expected first-quarter profit on Tuesday and raised its earnings and sales forecasts for the year, thanks to ...
  6. New Content Item

    Merck's Keytruda wins FDA approval as combination therapy for kidney cancer

    The U.S. Food and Drug Administration has approved Merck & Co Inc's cancer therapy, Keytruda, as part of a combination therapy for previously ...